Pharmaceutical scientists come up against a hard limitation here on Earth: gravity. Varda Space wants to change that.
The company has raised a massive new round to turn space into the “ultimate high ground” for the production of critical pharmaceutical components that can be brought back to Earth and used to make finished drugs.
The company’s $187 million Series C funding round announced Thursday will be used to build out a new laboratory facility that could transform Varda’s orbital manufacturing process into a lucrative…